​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $766.00, with a high of $766.00 and a low of $766.00. This represents a 8.46% increase from the last price of $706.28.

$450 $520 $590 $660 $730 $800 High: $766 Avg: $766 Low: $766 Last Closed Price: $706.28

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 25 Buy (80.65%), 5 Hold (16.13%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 5 25 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks

TypeNameUpside
StockMcKesson8.46%
SectorHealthcare Stocks 18.80%
IndustryMedical Distribution Stocks12.75%

Price Target Trends

1M3M12M
# Anlaysts-19
Avg Price Target-$766.00$631.56
Last Closing Price$706.28$706.28$706.28
Upside/Downside-8.46%-10.58%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 253103-117
Jun, 253103-117
May, 253103-117
Apr, 253103-117
Mar, 253103-117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 03, 2025Stephen BaxterWells Fargo$766.00$714.887.15%8.46%
Nov 19, 2024Rob DickersonJefferies$715.00$541.1532.13%1.23%
Nov 07, 2024Eric ColdwellRobert W. Baird$688.00$526.5430.66%-2.59%
Sep 25, 2024George HillDeutsche Bank$579.00$479.1620.84%-18.02%
Sep 24, 2024Eric ColdwellRobert W. Baird$531.00$505.005.15%-24.82%
Sep 13, 2024Stephen BaxterWells Fargo$535.00$511.174.66%-24.25%
Sep 06, 2024Michael ChernyLeerink Partners$665.00$514.7529.19%-5.84%
Sep 05, 2024Michael ChernyBank of America Securities$635.00$526.5020.61%-10.09%
Aug 08, 2024Ann HynesMizuho Securities$570.00$617.51-7.69%-19.30%
Jul 09, 2024Eric ColdwellRobert W. Baird$694.00$589.5317.72%-1.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 16, 2025Morgan StanleyOverweightOverweighthold
Nov 19, 2024JefferiesBuyBuyhold
Oct 01, 2024BarclaysPositivePositivehold
Sep 25, 2024Deutsche BankBuyBuyhold
Sep 24, 2024WedbushNeutraldowngrade
Sep 23, 2024JefferiesHoldHoldhold
Sep 13, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 06, 2024Leerink PartnersOutperformOutperformhold
Sep 05, 2024Bank of America SecuritiesBuyBuyhold
Aug 26, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-12 $6 $24 $42 $60 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-27.02$7.31$25.23$22.54-----
Avg Forecast$17.23$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$17.68$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$16.74$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-256.82%-69.40%-2.81%-18.36%-----

Revenue Forecast

$200B $270B $340B $410B $480B $550B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$238.23B$263.97B$276.71B$308.95B-----
Avg Forecast$240.05B$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$244.87B$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$234.74B$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %-0.76%1.18%0.29%-0.95%-----

Net Income Forecast

$-10B $-6B $-2B $2B $6B $10B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-4.34B$1.11B$3.56B$3.00B-----
Avg Forecast$-3.74B$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$-2.28B$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$-5.20B$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %15.99%-3.33%2.28%0.13%-----

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 25 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 31 Wall Street analysts, averages $766 over the next 12 months. The price target range spans from $766 at the low end to $766 at the high end, suggesting a potential 8.46% change from the previous closing price of $706.28.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a 8.46% upside, underperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the medical distribution stocks industry (12.75%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • July 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • June 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • May 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2025 is $32.69, marking a 45.03% increase from the reported $22.54 in 2024. Estimates for the following years are $36.82 in 2026, $41.28 in 2027, $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2025 is $360.18B, reflecting a 16.58% increase from the reported $308.95B in 2024. The forecast for 2026 is $396.03B, followed by $424.3B for 2027, $464.8B for 2028, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2025 stands at $4.38B, representing an 45.98% increase from the reported $3B in 2024. Projections indicate $4.91B in 2026, $5.31B in 2027, $6.29B in 2028, and $7.21B in 2029.